5-BROMO-N-(2-(4-((((CYCLOHEXYLAMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-2-METHOXY-3-PYRIDINECARBOXAMIDE SODIUM SALT
UNII 57839YY8KK
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-bromo-n-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-3-pyridinecarboxamide Sodium Salt, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 57839YY8KK.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 54916-25-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H27BrN4O5S.Na MNZKYWYSDCWWCV-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-bromo-n-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-3-pyridinecarboxamide Sodium Salt. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.